Article Text

other Versions

PDF
Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging
  1. Steven K White1,2,
  2. Daniel M Sado1,2,
  3. Andrew S Flett1,2,
  4. James C Moon1,2
  1. 1The Heart Hospital, London, UK
  2. 2Institute of Cardiovascular Science, University College London, London, UK
  1. Correspondence to Dr James C Moon, The Heart Hospital, 16–18 Westmoreland St, London W1G 8PH, UK; james.moon{at}uclh.nhs.uk

Abstract

The myocardial interstitial or extracellular space exists as a complex and dynamic environment, vital for normal cardiac structure and function. The physiological pathways for normal control of collagen turnover, and the pathological development of fibrosis are beginning to be understood, as are their relationships to cardiac remodelling and adverse outcomes. Emerging non-invasive imaging techniques (echocardiography, cardiovascular magnetic resonance, positron emission tomography) may allow a clearer understanding and measurement of these processes in vivo. Preliminary results are exciting, spanning valvular and congenital heart disease, cardiomyopathy and rarer diseases such as amyloid. In this review, such developments and research directions are explored, including the rapid developments in cardiovascular magnetic resonance T1 mapping and its use with contrast to derive extracellular volume. The authors present a state-of-the-art assessment of the strengths and weaknesses of each modality, and distil a framework to equip the reader with an understanding of the technical issues useful for the interpretation of emerging clinical studies.

  • Interstitial space
  • extracellular space
  • fibrosis
  • cardiac imaging techniques
  • cardiac function
  • imaging and diagnostics
  • MRI
  • myocardial fibrosis
  • myocardial ischaemia and infarction
  • cardiomyopathy
  • cardiac imaging
  • hypertrophic cardiomyopathy
  • myocardial infarction

Statistics from Altmetric.com

Footnotes

  • Funding ASF, DMS and SKW each hold a clinical research training fellowship from the British Heart Foundation. JCM is supported by the Higher Education Funding Council for England. This work was undertaken at the University College London Hospital and University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme.

  • Competing interests JCM with UCL business and in collaboration with Resonance Health Ltd have submitted a patent on EQ-CMR.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.